Single nucleotide polymorphism of Pi-class glutathione S-transferase and susceptibility to endometrial carcinoma

Clinical Cancer Research

Volumn 11, Issue 8, 2005, Pages 2981-2985

  Chan, Queeny K Y ^a   Khoo, Ui Soon ^a   Ngan, Hextan Y S ^a   Yang, Chong Qing ^a   Xue, Wei Cheng ^a   Chan, Kelvin Y K ^a   Chiu, Pui Man ^a   Ip, Philip P C ^a   Cheung, Annie N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; ISOLEUCINE; VALINE;

ADENOCARCINOMA; ADULT; AGED; ALLELE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MYOMETRIUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 17144395926     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-2038     Document Type: Article

References (37)

1. Coleman MP, Esteve J, Damiecki P, et al. Trends in cancer incidence and mortality. 1st ed. Lyon: IARC; 1993.
2. United States Cancer Statistics Working Group. United States Cancer Statistics: 1999 incidence. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2002.
3. Office for National Statistics. Population and health monitor MBI 98/2. London: Government Statistical Service; 1998.
4. NHS Centre for Reviews and Dissemination University of York. Management of gynaecological cancers. Effective Health Care Bulletin 1999;5.
5. The Hong Kong Cancer Registry. Department of Health Annual Report 1999/2000. Hong Kong: Hong Kong Department of Health, Hospital Authority; 2000.
6. Barakat RR. Contemporary issues in the management of endometrial cancer. CA Cancer J Clin 1998;48:299-314.
7. Rebbeck TR. Molecular epidemiology of the human glutathione-S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43.
8. Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Oncogene 1999;18:1313-24.
9. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
10. Mannervik B, Awasthi YC, Board PG, et al. Nomenclature for human glutathione transferases. Biochem J 1992;282:305-6.
11. Ishioka C, Kanamaru R, Shibata H, et al. Expression of glutathione S-transferase-pi messenger RNA in human esophageal cancers. Cancer 1991;67:2560-4.
12. Terrier P, Townsend AJ, Coindre JM, Triche TJ, Cowan KH. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol 1990;137:845-53.
13. Chan QKY, Khoo US, Chan KYK, et al. Promoter methylation and differential expression of pi-class glutathione-S-transferase in endometrial carcinoma. J Mol Diagn 2005;7:8-16.
14. Brooks JD, Weinstein M, Lin X, et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998;7:531-6.
15. Nakazato H, Suzuki K, Matsui H, et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res 2003;23:2897-902.
16. Kote-Jarai Z, Easton D, Edwards SM, et al. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 2001;11:325-30.
17. Ronnett BM, Zaino RJ, Ellenson LH, Kurman RJ. Endometrial carcinoma. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. New York: Springer-Verlag; 2002.
18. Zaino RJ. Endometrial hyperplasia and carcinoma. In: Fox H, Wells M, editors. Haines and Taylor obstetrical and gynaecological pathology. Edinburgh: Churchill Livingstone; 2003.
19. Sambrook J, Fritsch EF, Maniatia T. Molecular cloning: a laboratory manual. Plainview (NY): Cold Spring Harbor Laboratory Press; 1989.
20. Bernardini S, Melino G, Cortese C, et al. Modulation of glutathione transferase P1-1 activity by retinoic acid in neuroblastoma cells. J Cell Biochem 1999;75:375-81.
21. Sundberg K, Johansson AS, Stenberg G, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998;19:433-6.
22. Egan KM, Cai Q, Shu XO, et al. Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2004;13:197-204.
23. Mitrunen K, Jourenkova N, Kataja V, et al. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 2001;10:229-36.
24. Helzlsouer KJ, Selmin O, Huang HY, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 1998;90:512-8.
25. Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 2001;22:67-72.
26. Spepard TF, Platz EA, Kantoff PW, et al. No association between the I105 V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 2000;9:1267-8.
27. Jeronimo C, Varzim G, Henrique R, et al. I105 V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2002;11:445-50.
28. Longuemaux S, Delomenie C, Gallou C, et al. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 1999;59:2903-8.
29. To-Figueras J, Gene M, Gomez-Catalan J, et al. Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control 1999;10:65-70.
30. Wang J, Deng Y, Cheng J, Ding J, Tokudome S. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 2003;201:185-93.
31. Pae CU, Kim JJ, Lee SJ, et al. Association study between glutathione S-transferase P1 polymorphism and schizophrenia in the Korean population. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:519-23.
32. Nerurkar PV, Okinaka L, Aoki C, et al. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev 2000;9:1119-22.
33. Enomoto T, Fujita M, Inoue M, Nomura T, Shroyer KR. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado. Am J Clin Pathol 1995;103:224-30.
34. Khoo US, Chan KY, Cheung AN, et al. Recruuent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mutat 2002;19:307-8.
35. Srivastava SK, Singhal SS, Hu X, Awasthi YC, Zimniak P, Singh SV. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. Arch Biochem Biophys 1999;366:89-94.
36. Bradbury J. Ancient footsteps in our genes: evolution and human disease. Gene variants selected during evolution may underlie many common diseases. Lancet 2004;363:952-3.
37. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 2004;444:213-23.